Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Schinzel-Giedion syndrome (SGS) is an ectodermal dysplasia syndrome chiefly characterized by a distinctive facial dysmorphism, hydronephrosis, severe developmental delay, typical skeletal malformations, and genital and cardiac anomalies.
Features include rarely findings: Splenopancreatic fusion. 61 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 6 | Increased density of long bones, Aplasia/Hypoplasia of the pubic bone, Wide distal femoral metaphysis |
Brain and nerves | 5 | Seizure, Intellectual disability, Enlarged brain ventricles (ventriculomegaly) |
Head and neck | 2 | Coarse facial features, Facial hemangioma |
Growth and development | 2 | Postnatal growth retardation, Failure to thrive |
Digestive system | 2 | Hepatoblastoma, Splenopancreatic fusion |
Arms and legs | 2 | Short distal phalanx of finger, Postaxial hand polydactyly |
Skin | 1 | Hyperconvex nail |
Muscles | 1 | Brain shrinkage (cerebral atrophy) |
Heart and blood vessels | 1 | Atrial septal defect |
Classic Schinzel-Giedion syndrome (SGS), an ultra-rare multisystem disorder, is characterized by a range of physical and developmental abnormalities. The main features include global neurodevelopmental impairment leading to moderate-to-profound intellectual disability, epilepsy (often refractory to treatment), tone abnormalities, dysautonomia, and cerebral visual and hearing impairment. Poor weight gain is common and often associated with gastroesophageal reflux disease, chronic vomiting, constipation, gastroparesis, and/or feeding intolerance. Structural malformations can involve the heart, skeleton, kidney and urinary tract, genitalia, and brain. Rarely there may be anomalies of the liver, spleen, and/or pancreas.
Source: GeneReviews — "Schinzel-Giedion Syndrome"
SETBP1 function has not been fully characterized.
Schinzel-Giedion syndrome is caused by mutations in the SETBP1 gene on chromosome 18.
This chapter focuses on classic and atypical Schinzel-Giedion syndrome (SGS). Before pathogenic variants within SETBP1 were identified to cause classic Schinzel-Giedion syndrome (SGS), clinical diagnostic criteria for classic SGS were proposed .
Schinzel-Giedion syndrome (SGS) should be considered in a proband with the following clinical findings and family history.
Clinical findings
Moderate-to-profound developmental delay (DD) or intellectual disability (ID)
Facial features include a prominent forehead, midface retrusion, and bitemporal narrowing with or without other characteristics features . Although facial features are typical in both classic and atypical SGS, the facial features in individuals with atypical SGS are not as coarse.
Source: GeneReviews — "Schinzel-Giedion Syndrome"
The phenotypic features associated with classic Schinzel-Giedion syndrome (SGS) are often sufficient to diagnose this condition clinically. However, in individuals with findings in the moderate end of the spectrum of classic SGS (e.g., less apparent dysmorphisms, no hydronephrosis or other congenital anomalies and/or epilepsy) or atypical SGS, the following monogenic disorders , chromosomal anomalies, and teratogenic conditions may be considered in the differential diagnosis.
Table 4.
Selected Monogenic Disorders in the Differential Diagnosis of Classic and Atypical Schinzel-Giedion Syndrome
Gene | Disorder | MOI | Features of Disorder
Overlapping w/SGS | Distinguishing from SGS
ARSB
ARSK
GALNS
GLB1
GNS
GUSB
HGSNAT
HYAL1
IDS
IDUA
NAGLU
SGSH
Source: GeneReviews — "Schinzel-Giedion Syndrome"
Genetic testing for SETBP1 is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for Schinzel-Giedion syndrome. The disease remains an area of unmet medical need.
Gene therapy approaches for Schinzel-Giedion syndrome have been reported in the published literature.
No clinical practice guidelines for classic or atypical Schinzel-Giedion syndrome (SGS) have been published. The recommendations in this section reflect the authors' experience in the management of individuals with SGS. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with classic or atypical SGS, the evaluations summarized (if not performed as part of the evaluation that led to diagnosis) are recommended. Table 5. Schinzel-Giedion Syndrome: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment |
|---|---|---|
Constitutional | Physical exam | Measure head circumference, weight, length. |
Neurologic | Neurologic eval | To incl brain MRI; Consider EEG if seizures are a concern. |
Development | Developmental assessment | To incl motor, adaptive, cognitive, speech-language eval; Evaluate for early intervention/ special education |
Neurobehavioral | Eval by developmental pediatrician | For persons age 12 mos: screening for behavior concerns In case of severe sleep disturbances, consider polysomnography/EEG. |
Musculoskeletal | Orthopedics/ physical medicine rehab/ PT OT eval |
Source: GeneReviews — "Schinzel-Giedion Syndrome"
View trials for Schinzel-Giedion syndrome
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended.
Table 7.
Schinzel-Giedion syndrome: Recommended Surveillance
System/Concern | Evaluation | Frequency
| • Measurement of growth parameters (weight, height, head circumference)
Eval of nutritional status safety of oral intake incl swallowing problems/ dysphagia
| At each visit
| • Monitor for constipation.
Monitor gastroesophageal reflux disease perform additional GI assessments if needed.
In case of chronic vomiting, consider gastroparesis.
| Monitor for evidence of aspiration, breathing problems due to excess mucus production, respiratory insufficiency.
| • Monitor those w/seizures as clinically indicated.
Assess for new manifestations such as seizures, changes in tone, movement disorders.
Consider brain /or spine MRI depending on clinical changes (incl changes in mood, irritability, alertness).
| Per treating urologist | • Frequency based on clinical findings
Consider bladder atony when urinary tract infections are frequent persistent.
Per treating nephrologist | • Standard follow up of hydronephrosis renal function1
Frequency based on type of features
| Monitor developmental progress educational needs.
Source: GeneReviews — "Schinzel-Giedion Syndrome"
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Schinzel-Giedion syndrome.
12 publications have been identified in PubMed for Schinzel-Giedion syndrome. Research spans Basic Science / Preclinical (42%), Case Report / Case Series (25%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 5 | 42% |
Patient case studies | 3 | 25% |
Disease patterns and progression | 2 | 17% |
Other research | 1 | 8% |
New treatment approaches | 1 | 8% |
Thanugundla SR (2026). [PMID: 42255817](https://pubmed.ncbi.nlm.nih.gov/42255817/). *Cureus*. [Case Report / Case Series]
Antonyan L (2026). [PMID: 41612697](https://pubmed.ncbi.nlm.nih.gov/41612697/). *Molecular therapy : the journal of the American Society of Gene Therapy*. [Basic Science / Preclinical]
Soelter TM (2026). [PMID: 41757684](https://pubmed.ncbi.nlm.nih.gov/41757684/). *Disease models & mechanisms*. [Basic Science / Preclinical]
Zigler CK (2026). [PMID: 41114730](https://pubmed.ncbi.nlm.nih.gov/41114730/). *J Child Psychol Psychiatry*. [Epidemiology / Natural History]
Trinh MK (2026). [PMID: 41881778](https://pubmed.ncbi.nlm.nih.gov/41881778/). *Br J Haematol*. [Basic Science / Preclinical]
Antonyan L (2025). [PMID: 39825586](https://pubmed.ncbi.nlm.nih.gov/39825586/). *Human molecular genetics*. [Basic Science / Preclinical]
Beaman GM (2025). [PMID: 40123672](https://pubmed.ncbi.nlm.nih.gov/40123672/). *Frontiers in pediatrics*. [Case Report / Case Series]
Morison LD (2025). [PMID: 40859069](https://pubmed.ncbi.nlm.nih.gov/40859069/). *Neurogenetics*. [Other]
Duis J (2025). [PMID: 39967563](https://pubmed.ncbi.nlm.nih.gov/39967563/). *American journal of medical genetics. Part A*. [Gene Therapy / Novel Therapeutics]
Michaeli O (2025). [PMID: 39601780](https://pubmed.ncbi.nlm.nih.gov/39601780/). *Clinical cancer research : an official journal of the American Association for Cancer Research*. [Epidemiology / Natural History]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Feeding | Gastroenterology/ nutrition/ feeding team eval | To incl eval of swallowing, aspiration risk, nutritional status; Consider eval for gastrostomy tube or gastrostomy-jejunostomy tube placement in persons w/dysphagia /or aspiration risk. Assess for constipation. |
Eyes/vision | Ophthalmologic eval | To assess for reduced vision, abnormal ocular movement, strabismus, more complex findings (e.g., cataract, retinal dystrophy) that may require referral for subspecialty care /or low vision services Specialist assessment for cerebral visual impairment |
Hearing | Audiologic eval | Assess for sensorineural /or conductive hearing loss. |
Associated cancer1 | Sacrococcygeal teratoma | Perform pelvic ultrasound in children age ≤6 mos; Perform pelvic MRI in children age 6 mos Hepatoblastoma |
ENT | ENT eval | Attempt to insert flexible nasal endoscope to detect choanal stenosis/atresia.; Assess for tracheo- laryngomalacia; additional imaging may be needed.; Mgmt of drooling due to risk of aspiration |
Cardiovascular | Cardiology eval | Assess for congenital cardiac defects (mainly atrial septal defects).; Other defects incl patent foramen ovale, patent ductus arteriosus, cardiac hypertrophy. |
Respiratory | Pulmonary eval | Note that excessive mucus production may lead to breathing problems.; Assess for tracheo- laryngomalacia; additional imaging may be needed.; Lung ultrasound or MRI1 to exclude lung hypoplasia |
CAKUT | Urologic eval | Assess for UPJ obstruction or VUR hydronephrosis.; Exclude other renal/bladder anomalies such as abnormal ureters, cysts stones, bladder atony. |
Genital anomalies | Eval for genital anomalies | Males: assess for hypospadias, cryptorchidism, micropenis, hypoplastic scrotum.; Females: assess for abnormal labia, hypoplastic uterus.; Assess for an anteriorly displaced anus. |
Genetic counseling | By genetics professionals2 | To inform affected persons their families re nature, MOI, implications of SGS to facilitate medical personal decision making Family support resources |